Physician profile
Francis Gress
NPI 1851473631
$33,583.44
in general payments reported to CMS, 2019-2025
37 companies · $922 in 2025
The $922 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,282 · 2020: $434 · 2021: $1,382 · 2022: $18K · 2023: $1,286 · 2024: $2,090 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,193 · Consulting Fee: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,193.31 |
| Consulting Fee | $105.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu A/S | $16,917.36 | 2022 | |
| Pentax of America, INC. | $5,084.89 | 2019-2023 | Inspira, C2 Cryoballoon |
| US Endoscopy | $3,140.10 | 2019-2023 | |
| Olympus America INC. | $1,429.03 | 2019-2025 | Single Use Repositionable Clip, Endoclot Sis, Evis Eus Endoscopic Ultrasound Center |
| Cook Medical LLC | $1,194.81 | 2019-2025 | Echotip Insight, Hemospray, Fusion |
| Qol Medical, LLC | $1,023.94 | 2019-2025 | Sucraid, Sucraid |
| Abbvie INC. | $974.44 | 2019-2025 | |
| Steris Corporation | $548.49 | 2019-2025 | |
| Ambu INC. | $434.94 | 2021-2022 | |
| Boston Scientific Corporation | $392.17 | 2023-2024 | Apollo Esg System, Axios, Agile Esophageal |
| Intra-Sana Laboratories | $320.23 | 2022-2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Phathom Pharmaceuticals, INC. | $279.45 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $255.00 | 2023 | Imfinzi |
| Lucid Diagnostics INC. | $215.33 | 2021 | |
| Fujifilm Healthcare Americas Corporation | $207.27 | 2023-2024 | Fujifilm |
Show all 36 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Gress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.